| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 51.4× | 27.9× | |
| Price / Book | 5.7× | 4.1× | |
| Price / Sales | 8.5× | 2.9× | |
| Price / Free cash flow | −12.3× | −9.5× | |
| EV / EBITDA | 30.9× | 21.7× | |
| Earnings yield | 1.9% | 2.1% | |
| Free cash flow yield | −8.2% | −3.1% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LENSE:LENSKARTLenskart Solutions Ltd · 🇮🇳 NSE | ₹639.95 | −1.01% | $11.63B | 226.5× | 5.6% | — |
RUNSE:RUBICONRubicon Research Ltd · 🇮🇳 NSE | ₹1,486.70 | −1.45% | $2.53B | 99.0× | 19.1% | — |
MONSE:MOLBIOMolbio Diagnostics Limited · 🇮🇳 NSE | ₹1,434.80 | −8.87% | $1.58B | 113.4× | 15.0% | — |
CONSE:CORONACorona Remedies Ltd · 🇮🇳 NSE | ₹2,010.00 | +0.30% | $1.32B | 67.6× | 24.8% | — |
SYNSE:SYMBIOTECSymbiotec Pharmalab Limited · 🇮🇳 NSE | ₹1,238.60 | −3.20% | $820.94M | 83.4× |
| 11.9% |
| — |
KPNSE:KPLKwality Pharmaceuticals Ltd · 🇮🇳 NSE | ₹3,366.00 | −1.08% | $357.64M | 51.1× | 20.3% | — |
SHNSE:SHUKRAPHARShukra Pharmaceuticals Ltd. · 🇮🇳 NSE | ₹68.62 | −0.38% | $307.17M | 133.1× | 24.5% | — |
FRNSE:FREDUNFredun Pharmaceuticals Ltd. · 🇮🇳 NSE | ₹1,438.40 | −2.66% | $245.5M | 73.6× | 11.7% | — |
SANSE:SAIPARENTSai Parenteral's Ltd · 🇮🇳 NSE | ₹483.00 | −0.88% | $222.62M | 149.9× | 2.9% | — |
BENSE:BETABeta Drugs Ltd · 🇮🇳 NSE | ₹1,719.60 | −3.56% | $196.6M | 46.8× | 16.9% | −2.0% |
